Over the last several months, I have been thinking about how we can deliver consistent, high-quality surgical care to your patients. In 2001, the Institute of Medicine produced a report titled, Crossing the Quality Chasm. In this report, they state:
FOLFIRINOX has become the standard of care for metastatic pancreatic cancer. It has promising results and has improved survival for pancreatic cancer. FOLFIRINOX is a 4-drug treatment regimen, consisting of 5-fluorouracil, leucovorin, irinotecan, and oxaliplatin. It’s producing the greatest prolonging
Incidence and Mortality Primary liver cancer (including intrahepatic bile duct cancer) is the fifth most common cause of cancer death in men and the ninth most common cause of cancer death in women. Over the past two decades, incidence rates